International Clinical Trials is a company that specializes in the application of the latest scientific technologies to the pharmaceutical industry. These technologies possess great sensitivity & specificity that differentiates between the effects of heavily sedating & minimally sedating drugs on driving skills. There is a strong unmet need for drugs that are safer for patients who drive cars or operate equipment because 43% of deceased US road traffic accident victims had drugs and 37% had alcohol found in their bloodstream. Contact us to ensure that our unique research methodologies ensure maximum commercialization of your drug and save lives by reducing motor vehicle accidents. MISSION STATEMENT International Clinical Trials passionate mission is to constantly strive to find medications that are safer for patients who drive vehicles & operate machinery. VISION STATEMENT Continuous annual worldwide reduction in deaths,serious injuries and property damage caused by motor vehicle accidents. BUSINESS MODEL International Clinical Trials business model is based on partnerships with other pharmaceutical companies that possess antipsychotic compounds with low degrees of sedation. Commercial returns for these drugs are maximized throughout their product life cycle by early clinical trial comparisons with strongly sedating antipsychotic agents.